Showing results (1-10 of 294) with videos related to
Sort By:
Pageof 30
Current Opinion in Investigational Drugs (London, England : 2000)|June 21, 2006
Advances in oncolytic viral therapyYanghee Woo, Prasad S Adusumilli, Yuman FongCancer Discovery|October 28, 2015
Mesothelin-Targeted CARs: Driving T Cells to Solid TumorsAurore Morello, Michel Sadelain, Prasad S AdusumilliTranslational Lung Cancer Research|July 18, 2017
Immunotherapy for malignant pleural mesothelioma: current status and future directionsJordan Dozier, Hua Zheng, Prasad S AdusumilliJournal of Mammary Gland Biology and Neoplasia|July 11, 2006
Employing tumor hypoxia for oncolytic therapy in breast cancerYun Shin Chun, Prasad S Adusumilli, Yuman FongImmunotherapy|October 11, 2012
Safety and stability of retrovirally transduced chimeric antigen receptor T cellsChristos Colovos, Jonathan Villena-Vargas, Prasad S AdusumilliClinical Epidemiology|October 1, 2019
Reporting net survival in populations: a sensitivity analysis in lung cancer demonstrates the differential implications of reporting relative survival and cause-specific survivalKay See Tan, Takashi Eguchi, Prasad S AdusumilliLung Cancer (Amsterdam, Netherlands)|November 5, 2022
Pathologic node-negative lung cancer: Adequacy of lymph node yield and a tool to assess the risk of occult nodal diseaseKay See Tan, Meier Hsu, Prasad S AdusumilliOncoimmunology|June 14, 2013
Prognostic value of the immune microenvironment in lung adenocarcinomaKyuichi Kadota, Jun-Ichi Nitadori, Prasad S AdusumilliThe National Medical Journal of India|March 27, 2009
Lung transplantation in India: a possible treatment optionKalpaj R Parekh, Prasad S Adusumilli, G Alexander PattersonPharmacology & Therapeutics|December 1, 2024
Combinational CAR T-cell therapy for solid tumors: Requisites, rationales, and trialsKyohei Misawa, Hina Bhat, Prasad S Adusumilli, et al.Pageof 30